Peptides and steroids on TikTok: separating hype from human data

What did @gregbodylab actually say?

The short version: a 16-year-old competitive powerlifter admitted to using "serums" alongside pre-workouts, creatine, and amino acids, then claimed he was safe. Greg pushed back hard, telling him directly, "as soon as you add the word you're taking serums, you are not safe." He says he's been trying to convince the teenager to stop via DMs, and frames serums as categorically dangerous for adolescents.

The word "serums" here is doing a lot of work. In context, it almost certainly refers to peptides, possibly injectable compounds like BPC-157, TB-500, or growth hormone secretagogues like ipamorelin. Greg doesn't specify, and neither does the teen. That ambiguity matters for the fact-check, because "serum" could also mean topical products, though the powerlifting and PED context strongly suggests injectables.

Does the science back this up?

On the core claim, yes, mostly. The idea that adolescents should not be using performance-enhancing peptides or anabolic compounds has real biological support, and Greg is not wrong to sound the alarm.

The adolescent endocrine system is not a miniature adult one. Testosterone peaks naturally during puberty, and the hypothalamic-pituitary-gonadal axis is actively calibrating itself through the teenage years. Introducing exogenous androgens or peptides that stimulate growth hormone release, like CJC-1295 or ipamorelin, during this window carries specific risks that don't apply in the same way to adults. A 2021 review by Nicholls et al. in the British Journal of Sports Medicine found that early-onset PED use in adolescents is associated with premature epiphyseal closure, disrupted hormonal feedback loops, and elevated cardiovascular risk markers. For peptides specifically, long-term adolescent data is essentially nonexistent, which is its own problem.

The blanket statement that serums are never safe at any dose or age is harder to defend scientifically, but in the context of a 16-year-old using unregulated compounds without medical supervision, it's a defensible public health position.

What did they get wrong (or right)?

Greg gets the broad strokes right. Teenagers should not be using injectable peptides or any performance-enhancing compounds outside of supervised medical treatment for a diagnosed condition. That is not a controversial position, and he deserves credit for saying it plainly on a platform where peptide culture is frequently glamorized.

What he gets wrong, or at least imprecise, is the sweeping claim that serums are categorically unsafe with zero qualification. Some peptides, like BPC-157, are being studied in clinical contexts for wound healing and gastrointestinal repair. GHK-Cu is in topical cosmetic formulations. Calling all of these "not safe" without distinction conflates a teenager injecting unlicensed growth hormone secretagogues with someone using a dermatologist-supervised topical. Precision matters in health communication, especially on TikTok where clips get clipped.

He also doesn't address why the teen might be drawn to these compounds in the first place. Recovery pressure, training load, and coach influence are real drivers of adolescent PED use. A study by Smurthwaite et al. (2020, Performance Enhancement and Health) found social normalization within sport environments was the leading predictor of adolescent PED initiation. Calling it dangerous without addressing the pull doesn't do much for prevention.

What should you actually know?

If you're under 18 and thinking about peptides for performance or recovery, the honest answer from the literature is that we don't have safety data for this population. That's not a technicality. It means the risk profile is genuinely unknown, and unknown is not the same as safe.

Peptides like BPC-157 and TB-500 have not completed Phase 3 clinical trials in adults, let alone adolescents. CJC-1295 and ipamorelin affect pituitary signaling, and the pituitary is still developing through late adolescence. A 2019 paper by Devesa et al. in the International Journal of Molecular Sciences noted that growth hormone axis disruption during adolescence can have lasting effects on final adult height, metabolic function, and gonadal hormone balance.

Greg's instinct is right. The setting is wrong for these compounds at 16. But the broader point for anyone reading this is that "natural" peptide marketing often obscures real physiological risk, and the absence of a prescription does not mean the absence of harm. If you are an adult exploring peptides for legitimate therapeutic reasons, do it through a licensed telehealth provider who can order labs and monitor your response.